Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost Laser-Assisted Delivery for Hypopigmented Scars
NCT06122090Phase 2Recruiting
- Sponsor
- MedStar Health Research Institute
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bimatoprost in hypopigmentation, Hypertrophic Scar (HS), sponsored by MedStar Health Research Institute. Started Jul 2023; status: recruiting.
02
Drugs
bimatoprost
03
Conditions
hypopigmentationHypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT06122090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06122090.